or Try an Advanced Search...

    Cancer Vaccine Stocks List

    Symbol Grade Name % Change
    RENB F Renovaro Biosciences Inc. 5.75
    MRNA C Moderna, Inc. 0.17
    INDP D Indaptus Therapeutics, Inc. -3.75
    EVAX D Evaxion Biotech A/S -2.87
    AGEN D Agenus Inc. 3.43
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Vaccine stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 8.33
    BBH B Market Vectors Biotech ETF 5.98
    GNOM D Global X Genomics & Biotechnology ETF 5.54
    IDNA B iShares Genomics Immunology and Healthcare ETF 5.51
    IBBQ B Invesco Nasdaq Biotechnology ETF 4.91
    View all Cancer Vaccine ETFs...
    Compare ETFs
    Compare BBH to GNOM Compare GERM to BBH Compare GERM to GNOM

        Cancer Vaccine Stocks Recent News

        Date Stock Title
        May 17 MRNA Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
        May 17 MRNA European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
        May 17 MRNA Moderna vaccine patent upheld by European Patent Office: report
        May 17 MRNA Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 MRNA Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 MRNA The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 17 MRNA Could Novavax Become the Next Moderna?
        May 16 MRNA Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 MRNA Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
        May 16 AGEN FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
        May 15 MRNA Moderna Q1: A Promising Pipeline Is Undervalued
        May 14 MRNA Evercore says biotech ‘winter is finally thawing’
        May 14 MRNA Is This a Setback for Moderna?
        May 13 MRNA As 'Roaring Kitty' Returns, Here Are 3 ETFs To Leverage The 2024 Meme Stock Wave
        May 13 MRNA Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
        May 13 MRNA While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
        May 13 MRNA Company News For May 13, 2024
        May 13 MRNA Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
        May 13 MRNA Bull Market and Beyond: 2 Stocks Just Waiting to Soar
        May 13 MRNA Moderna to Present at Upcoming Conferences in May/June 2024
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy
        Cancer Vaccine

        A cancer vaccine is a type of immunotherapy that uses a person’s own immune system to fight cancer. It works by stimulating the body’s natural defenses to recognize and attack cancer cells. Cancer vaccines are designed to target specific types of cancer, such as breast, lung, or prostate cancer. They may also be used to prevent cancer from developing in the first place.

        Browse All Tags